United Laboratories prices Hong Kong IPO at the top

Institutional investors get 70% of the $105 million offering from the Chinese drug maker. Retail subscriptions are less overwhelming.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES